Salim Bwagu does not begin a conversation about cancer with statistics or public health slogans; he starts with a family portrait. A seventy-eight-year-old father who has never spent a night in a hospital bed, a mother in her late sixties whose strength he describes as unshakeable, and seven children raised in a household with no known history of the disease. Then that portrait changes. Of those seven children, three developed cancer. One sister survived Hodgkin’s lymphoma, another succumbed to acute myeloid leukemia, and Salim himself was diagnosed with Hodgkin’s lymphoma at the age of five. In a family with no traceable history of the condition, Salim’s story could have ended as private grief. Instead, he has turned it into a public argument. “Cancer does not wait for a warning; it does neither consult a family tree nor discriminate by class or social status,” he says. “It simply arrives.” Salim’s file at the Uganda Cancer Institute (UCI) was opened between 1987 and 1997, an era when childhood cancer diagnosis in Uganda carried minimal infrastructure, sparse awareness, and a fraction of today’s medical hope. His treatment was not a single, continuous course, but an ordeal broken repeatedly by circumstance, shifting on and off depending on his body’s response and his family’s strained finances. “I remember travelling to Kampala twice every six months to access treatment, a routine that persisted for years before the swellings that marked my illness finally disappeared,” he notes. He was officially declared cancer-free in 2007. What distinguishes Salim’s account from a conventional survivorship narrative is his insistence that recovery is not merely a triumph of biology. He remembers with gratitude a man named Jimmy Kwizera, who ran an organization that visited patients every Friday at UCI and freely covered Salim’s medical bills. That act, Salim says, more than the medicine itself, determined the trajectory of his adult life. Today, Salim works as a data protection specialist, holding both a degree in Computer Science and a Bachelor of Laws from the Islamic University in Uganda. Alongside that professional identity sits another, built entirely voluntarily: Salim acts as a patient navigator alongside his surviving sister. Together, they identify people newly confronting a cancer diagnosis, walk them through what to expect, and refer them to UCI, replicating the intervention that rescued his own treatment journey. It is, he says, the debt he owes to a system and a stranger that refused to let his file close prematurely. Salim is equally candid about what holds patients back, moving his account from memoir to critique. Fear, he argues, remains one of the Institute’s most stubborn adversaries, operating independently of access or cost. He points specifically to women who avoid breast screenings and men who fear prostate cancer screenings not because clinics are unavailable, but because they dread what a diagnosis might mean. It is a fear he understands intimately, but insists is misplaced, noting from his own experience that early detection did not make the disease more frightening; it made it more manageable. “The earlier the better,” he repeats, not as a marketing slogan, but as lived testimony. He acknowledges the human face of treatment at UCI, praising doctors who extended their responsibilities far beyond hospital walls. He describes clinicians who followed up with him and his sisters after appointments, permitted phone consultations when travel was impossible, and treated their caseload with genuine passion rather than routine obligation. That dedication, alongside financial support and community referral, is what keeps patients tethered to treatment through its hardest stretches. Salim extends his argument directly to policy, calling on political leaders at every level of government to make cancer awareness and treatment financing a visible part of their platforms. He is unmistakable that individual survivorship stories, his own included, cannot substitute for structural investment. To that end, he applauds the Uganda Cancer Institute’s expansion of regional cancer centers across the country as one of its most consequential decisions, easing pressure on the main center in Kampala and shortening the physical distance between diagnosis and treatment for families who might otherwise repeat his early struggles with logistics and cost. He offers similar praise to the non-governmental organizations partnering with UCI through funding and advocacy, describing their support as inseparable from the Institute’s capacity to carry patients through long, uncertain treatment journeys. Salim’s story resists a tidy ending, and he does not offer one. He does not describe cancer as a chapter that closed cleanly in 2007. It remains present in the sister he lost, in the sister who survived alongside him and now shares in his work caring for children, and in every new patient he guides toward UCI’s doors. What he offers instead is a standing argument, built from close to thirty-eight years of lived experience, that Uganda’s fight against cancer will be won not only in laboratories and hospital wards, but in early screening habits, community vigilance, sustained referral, and a public willingness to close, rather than widen, the gap between a family’s resources and a patient’s chance at survival.The post Diagnosed at five: How one cancer survivor is changing healthcare appeared first on The Observer Media Ltd.